loadpatents
name:-0.035019874572754
name:-0.027453899383545
name:-0.0054600238800049
Abrahmsen; Lars Patent Filings

Abrahmsen; Lars

Patent Applications and Registrations

Patent applications and USPTO patent grants for Abrahmsen; Lars.The latest application filed is for "her2 binders".

Company Profile
5.29.32
  • Abrahmsen; Lars - Valhallavagen SE
  • Abrahmsen; Lars - Stockholm SE
  • Abrahmsen; Lars - Bromma SE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Her2 Binders
App 20210170057 - Syud; Faisal Ahmed ;   et al.
2021-06-10
HER2 binders
Grant 10,894,097 - Syud , et al. January 19, 2
2021-01-19
Polypeptides
App 20200199197 - Ekblad; Caroline ;   et al.
2020-06-25
Polypeptides
Grant 10,562,955 - Ekblad , et al. Feb
2020-02-18
Polypeptide libraries with a predetermined scaffold
Grant 10,556,933 - Abrahmsen , et al. Feb
2020-02-11
Polypeptides
App 20190375799 - Ekblad; Caroline ;   et al.
2019-12-12
Neonatal Fc Receptor Binding Dimer and Methods of Use
App 20190284241 - Abrahmsen; Lars ;   et al.
2019-09-19
Her2 Binders
App 20190262481 - Syud; Faisal Ahmed ;   et al.
2019-08-29
Polypeptides
Grant 10,329,331 - Ekblad , et al.
2019-06-25
Neonatal Fc receptor binding dimer and methods of use
Grant 10,323,066 - Abrahmsen , et al.
2019-06-18
HER2 binders
Grant 10,159,760 - Syud , et al. Dec
2018-12-25
Compositions, methods and uses
Grant 10,118,949 - Abrahmsen , et al. November 6, 2
2018-11-06
Polypeptides
App 20180230235 - Abrahmsen; Lars ;   et al.
2018-08-16
Polypeptides
Grant 9,975,943 - Ekblad , et al. May 22, 2
2018-05-22
Polypeptides
App 20180118807 - Ekblad; Caroline ;   et al.
2018-05-03
Polypeptides
Grant 9,957,330 - Abrahmsen , et al. May 1, 2
2018-05-01
New Polypeptides
App 20170260238 - Abrahmsen; Lars ;   et al.
2017-09-14
Polypeptide Libraries With A Predetermined Scaffold
App 20170008936 - Abrahmsen; Lars ;   et al.
2017-01-12
Polypeptide libraries with a predetermined scaffold
Grant 9,469,670 - Abrahmsen , et al. October 18, 2
2016-10-18
New Polypeptides
App 20160289337 - Abrahmsen; Lars ;   et al.
2016-10-06
Her2 Binders
App 20160199521 - Syud; Faisal Ahmed ;   et al.
2016-07-14
Polypeptides
App 20160108095 - Ekblad; Caroline ;   et al.
2016-04-21
Polypeptides
App 20160031967 - Ekblad; Caroline ;   et al.
2016-02-04
Polypeptides
Grant 9,211,344 - Ekblad , et al. December 15, 2
2015-12-15
Immunoglobulin G Fc region binding polypeptide
Grant 9,175,067 - Abrahmsen November 3, 2
2015-11-03
Compositions, Methods And Uses
App 20150158916 - Abrahmsen; Lars ;   et al.
2015-06-11
Compositions, methods and uses
Grant 8,937,153 - Abrahmsen , et al. January 20, 2
2015-01-20
Polypeptides having affinity for HER2
Grant 8,883,120 - Abrahmsen , et al. November 11, 2
2014-11-11
Polypeptides
App 20140162956 - Ekblad; Caroline ;   et al.
2014-06-12
Polypeptides Having Affinity For Her2
App 20130280164 - Abrahmsen; Lars ;   et al.
2013-10-24
Immunoglobulin G Fc Region Binding Polypeptide
App 20130203962 - Abrahmsen; Lars
2013-08-08
Polypeptides having affinity for HER2
Grant 8,501,909 - Abrahmsen , et al. August 6, 2
2013-08-06
Her2 Binders
App 20120165650 - Syud; Faisal Ahmed ;   et al.
2012-06-28
Polypeptide
App 20110144302 - Jarstad; Anders ;   et al.
2011-06-16
Polypeptides Having Affinity For Her2
App 20110020223 - Abrahmsen; Lars ;   et al.
2011-01-27
Polypeptide Libraries With A Predetermined Scaffold
App 20100286366 - Abrahmsen; Lars ;   et al.
2010-11-11
Compositions, Methods And Uses
App 20100273979 - Abrahmsen; Lars ;   et al.
2010-10-28
Modified Chimeric superantigens and their use
Grant 7,226,595 - Antonsson , et al. June 5, 2
2007-06-05
Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
Grant 7,226,601 - Abrahmsen , et al. June 5, 2
2007-06-05
Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
App 20060062795 - Abrahmsen; Lars ;   et al.
2006-03-23
Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
App 20050260215 - Abrahmsen, Lars ;   et al.
2005-11-24
Cytolysis of target cells by superantigen conjugates inducing T-cell activation
Grant 6,962,694 - Soegaard , et al. November 8, 2
2005-11-08
Cytolysis of target cells by superantigen conjugates inducing T-cell activation
App 20050226885 - Soegaard, Morten ;   et al.
2005-10-13
Methods for protein purification
App 20050186659 - Abrahmsen, Lars ;   et al.
2005-08-25
Promoter sequences
App 20040191759 - Abrahmsen, Lars ;   et al.
2004-09-30
Promoter sequences
Grant 6,723,553 - Abrahmsen , et al. April 20, 2
2004-04-20
Dimer of molecular variant of apolipoprotein and processes for the production thereof
Grant 6,617,134 - Sirtori , et al. September 9, 2
2003-09-09
Modified chimeric superantigens and their use
App 20030092894 - Antonsson, Per ;   et al.
2003-05-15
Modified/chimeric superantigens and their use
Grant 6,514,498 - Antonsson , et al. February 4, 2
2003-02-04
Methods for protein purification
App 20020160482 - Abrahmsen, Lars ;   et al.
2002-10-31
Promoter sequences
App 20020082404 - Abrahmsen, Lars ;   et al.
2002-06-27
Serine protease variants having peptide ligase activity
Grant 5,736,512 - Abrahmsen , et al. April 7, 1
1998-04-07
Methods of use of serine protease variants having peptide ligase activity
Grant 5,629,173 - Abrahmsen , et al. May 13, 1
1997-05-13
Construction of an IgG binding protein to facilitate downstream processing using protein engineering
Grant 5,143,844 - Abrahmsen , et al. September 1, 1
1992-09-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed